Search Medical Condition
Please enter condition
Please choose location from dropdown

Cairo, Egypt Clinical Trials

A listing of Cairo, Egypt clinical trials actively recruiting patients volunteers.

RESULTS

Found (340) clinical trials

Biomarker for Hereditary Angioedema Disease Type 1 (BioHAE)

Hereditary angioedema is a rare inherited disorder characterized by recurrent episodes of the accumulation of fluids outside of the blood vessels, blocking the normal flow of blood or lymphatic fluid and causing rapid swelling of tissues in the hands, feet, limbs, face, intestinal tract, or airway. Usually, this swelling is ...

Phase N/A

0.0 miles

Learn More »

Gonapure in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI

Gonapure is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin and contains no luteinizing hormone (LH) activity. FSH stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Gonapure is the primary hormone responsible for follicular recruitment and development. ...

Phase

0.0 miles

Learn More »

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

This Phase 3, multicenter, randomized, double-blind, placebo controlled study is designed to evaluate the efficacy and safety of atezolizumab (MPDL3280A, an anti-programmed death-ligand 1 [PD-L1] antibody) administered in combination with paclitaxel compared with placebo in combination with paclitaxel in participants with previously untreated, inoperable locally advanced or metastatic, centrally confirmed ...

Phase

0.0 miles

Learn More »

Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.

OPTIMISE study objectives are dual and aim primarily to increase the knowledge regarding the outcomes from Sunitinib use on one hand; and outcomes from the combined Sunitinib-2nd line sequence on the other hand in real life clinical practice. This will be addressed in many countries across AfME and in individual ...

Phase N/A

0.0 miles

Learn More »

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

The development of factor VIII inhibitors occurs in approximately 30 to 40% of patients with severe Haemophilia A. The main negative clinical and cost consequence is the ineffectiveness of replacement therapy in patients with high-titer antibodies, who have a shorter life and greater morbidity than those who do not develop ...

Phase

0.0 miles

Learn More »

Biomarker for Hypophosphatasia Disease (BioHypophos)

Hypophosphatasia (HPP) is a rare genetic disorder characterized the abnormal development of bones and teeth. These abnormalities occur due to defective mineralization, the process by which bones and teeth take up minerals such as calcium and phosphorus. These minerals are required for proper hardness and strength. Defective mineralization results in ...

Phase N/A

0.0 miles

Learn More »

Biomarker for Patients With Cystic Fibrosis (BioCyFi)

Cystic Fibrosis (CF) is an inherited disease characterized by the buildup of thick, sticky mucus that can damage many of the body's organs. The disorder's most common signs and symptoms include progressive damage to the respiratory system and chronic digestive system problems. The feature of the disorder and their severity ...

Phase N/A

0.0 miles

Learn More »

Biomarker for Gilbert Disease (BioGilbert)

Gilbert syndrome is a mild genetic liver disorder in which the body cannot properly process bilirubin, a yellowish waste product that is formed when old or worn out red blood cells are broken down (hemolysis). It is inherited as an autosomal recessive trait. Individuals with Gilbert syndrome have elevated levels ...

Phase N/A

0.0 miles

Learn More »

Biomarker for Alport Disease (BioAlport)

Alport syndrome (AS) is an inherited disease that affects the glomeruli of kidneys with hematuria, progressing to end-stage renal disease, associated with sensorineural deafness. This disease is caused by changes in COL4A3, COL4A4, and COL4A5 genes (pathogenic variants) that affect type IV collagen, a protein that is important to the ...

Phase N/A

0.0 miles

Learn More »

Biomarker for Patients With Fabry Disease (BioFabry)

Fabry disease is a progressive, inherited, multisystemic lysosomal storage disease characterized by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations. Annual incidence is reported to be 1 in 80,000 live births but this figure may underestimate disease prevalence. When late-onset variants of the disease are considered, a prevalence of ...

Phase N/A

0.0 miles

Learn More »